StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
NASDAQ CALA opened at $0.01 on Friday. The firm’s fifty day moving average price is $0.02 and its 200 day moving average price is $0.02. Calithera Biosciences has a 12 month low of $0.01 and a 12 month high of $0.13.
Calithera Biosciences Company Profile
Featured Articles
- Five stocks we like better than Calithera Biosciences
- How to Effectively Use the MarketBeat Ratings Screener
- Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
- What are earnings reports?
- Has This Leading Tech Stock Halted the AI Surge?
- What is the S&P 500 and How It is Distinct from Other Indexes
- Revolutionary Battery Stock Gains Momentum with 3D Silicon-Anodes
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.